88IV - PR Newswire Asia's news


Monash University and ClinChoice Forge Strategic Partnership to Accelerate Clinical Development of Innovative Therapies MELBOURNE, Australia , March 23, 2026 /PRNewswire/ -- Monash University and ClinChoice Inc, a leading global clinical Contract Research Organization (CRO) focused on innovative therapeutics, today announced ... 2026-03-23T Biotechnology Education Health Care/Hospital Higher Education
Harbour BioMed Reports the Online Publication of Phase I Results for HBM9378 (SKB378/WIN378), a TSLP-Targeting Antibody CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , March 23, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery ... 2026-03-23T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Innovent Announces First Participant Dosed of IBI128 (Tigulixostat, XOI) in Phase 3 Clinical Study SAN FRANCISCO and SUZHOU, China , March 23, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures ... 2026-03-23T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
World Water Day: WuXi Biologics Advances Water Stewardship and Achieves Water Target SHANGHAI , March 22, 2026 /PRNewswire/ -- On the occasion of World Water Day, WuXi Biologics reaffirms its commitment to sustainability through responsible operations and efficient, circular water‑use ... 2026-03-22T Biotechnology Environmental Products & Services Health Care/Hospital
Dizal Announces Positive Topline Phase 3 Results from WU-KONG28 Study: Evaluating Oral, Once-Daily ZEGFROVY® (Sunvozertinib) vs. Platinum-Containing Chemo Doublet in First-Line Non-Small Cell Lung Cancer (NSCLC) with EGFR Exon 20 Insertion Mutation (exon20ins) Treatment with ZEGFROVY ® resulted in statistically significant and clinically meaningful improvement in progression free survival (PFS) over platinum-containing chemo doublet WU-KONG 28 ... 2026-03-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Quality Protein No Longer a Luxury? Angel Yeast Shows How at FIC 2026 SHANGHAI , March 20, 2026 /PRNewswire/ -- Angel Yeast (SH600298) showcased its latest yeast protein R&D achievements and progress in global applications at FIC 2026 from March 17-19, 2026, ... 2026-03-20T Beverages Biotechnology Computer/Electronics
Henlius Reports 2025 Results: Sustained Growth in Both Revenue and Profit, Advancing Innovation Validation and Global Operations SHANGHAI , March 20, 2026 /PRNewswire/ -- Henlius (2696.HK) today announced its annual results for the year ended December 31, 2025. During the reporting period, the Company recorded revenue of RMB 6.6666 ... 2026-03-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Earendil Labs Announces $787 Million in Financing to Scale AI-Driven Biologics Discovery and Development WILMINGTON, Del. , March 20, 2026 /PRNewswire/ -- Earendil Labs, an AI-driven biotechnology company advancing next-generation biologics, today announced that it has raised $787 million in financing ... 2026-03-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Antengene Announces 2025 Full-Year Results: First TCE Out-licensing Validates Platform Value and Marks Inflection Point Towards 2026 Profitability SHANGHAI and HONG KONG , March 20, 2026 /PRNewswire/ -- Antengene Corporation Limited ( "Antengene" , SEHK: 6996.HK) today announced its full-year results for the period ending December 31, ... 2026-03-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Tescan Opens New Demo Lab in Korea to Support Semiconductor Failure Analysis, Reliability, and Academic Research Across Asia-Pacific Integrated demo lab and office site brings demonstrations, training, and workflow support closer to semiconductor and academic users across APAC . ... 2026-03-20T Biotechnology Computer/Electronics Semiconductors

PR Newswire Asia's news > Biotechnology